1. Market Research
  2. > Spirogen Ltd. - Product Pipeline Review - 2013

Spirogen Ltd. - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 34 pages

Spirogen Ltd. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Spirogen Ltd. - Product Pipeline Review - 2013” provides data on the Spirogen Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Spirogen Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Spirogen Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Spirogen Ltd. - Brief Spirogen Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Spirogen Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Spirogen Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Spirogen Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Spirogen Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Spirogen Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Spirogen Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Spirogen Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Spirogen Ltd. and identify potential opportunities in those areas.

Table Of Contents

Spirogen Ltd. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Spirogen Ltd. Snapshot 5
Spirogen Ltd. Overview 5
Key Information 5
Key Facts 5
Spirogen Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Spirogen Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Spirogen Ltd. - Pipeline Products Glance 12
Spirogen Ltd. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Spirogen Ltd. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Spirogen Ltd. - Drug Profiles 16
SG-2000 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
AS-1-145 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Conjugated PBD Program 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
SG-2285 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
SG-2274 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
Spirogen Ltd. - Pipeline Analysis 23
Spirogen Ltd. - Pipeline Products by Therapeutic Class 23
Spirogen Ltd. - Pipeline Products by Target 24
Spirogen Ltd. - Pipeline Products by Route of Administration 25
Spirogen Ltd. - Pipeline Products by Molecule Type 26
Spirogen Ltd. - Pipeline Products by Mechanism of Action 27
Spirogen Ltd. - Recent Pipeline Updates 28
Spirogen Ltd. - Dormant Projects 31
Spirogen Ltd. - Locations And Subsidiaries 32
Head Office 32
Other Locations and Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 34
Disclaimer 34



List of Tables

Spirogen Ltd., Key Information 5
Spirogen Ltd., Key Facts 5
Spirogen Ltd. - Pipeline by Indication, 2013 7
Spirogen Ltd. - Pipeline by Stage of Development, 2013 8
Spirogen Ltd. - Monotherapy Products in Pipeline, 2013 9
Spirogen Ltd. - Partnered Products in Pipeline, 2013 10
Spirogen Ltd. - Partnered Products/ Combination Treatment Modalities, 2013 11
Spirogen Ltd. - Phase II, 2013 12
Spirogen Ltd. - Phase I, 2013 13
Spirogen Ltd. - Preclinical, 2013 14
Spirogen Ltd. - Discovery, 2013 15
Spirogen Ltd. - Pipeline by Therapeutic Class, 2013 23
Spirogen Ltd. - Pipeline by Target, 2013 24
Spirogen Ltd. - Pipeline by Route of Administration, 2013 25
Spirogen Ltd. - Pipeline by Molecule Type, 2013 26
Spirogen Ltd. - Pipeline Products by Mechanism of Action, 2013 27
Spirogen Ltd. - Recent Pipeline Updates, 2013 28
Spirogen Ltd. - Dormant Developmental Projects,2013 31
Spirogen Ltd., Other Locations 32



List of Figures

Spirogen Ltd. - Pipeline by Top 10 Indication, 2013 7
Spirogen Ltd. - Pipeline by Stage of Development, 2013 8
Spirogen Ltd. - Monotherapy Products in Pipeline, 2013 9
Spirogen Ltd. - Pipeline by Top 10 Therapeutic Class, 2013 23
Spirogen Ltd. - Pipeline by Top 10 Target, 2013 24
Spirogen Ltd. - Pipeline by Top 10 Route of Administration, 2013 25
Spirogen Ltd. - Pipeline by Top 10 Molecule Type, 2013 26
Spirogen Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2013 27



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.